Tracking the evolution of multiple in vitro hepatitis C virus replicon variants under protease inhibitor selection pressure by 454 deep sequencing.
about
Treatment of chronic hepatitis C with direct-acting antivirals: The role of resistanceVirologic Tools for HCV Drug Resistance TestingViral quasispecies evolutionCopy number variation of genes involved in the hepatitis C virus-human interactomeHCV genotypes are differently prone to the development of resistance to linear and macrocyclic protease inhibitorsA new stochastic model for subgenomic hepatitis C virus replication considers drug resistant mutantsSpecific detection of naturally occurring hepatitis C virus mutants with resistance to telaprevir and boceprevir (protease inhibitors) among treatment-naïve infected individuals.A system for the continuous directed evolution of proteases rapidly reveals drug-resistance mutationsPreexisting drug-resistance mutations reveal unique barriers to resistance for distinct antiviralsApplications of next-generation sequencing technologies to diagnostic virology.Deep sequencing and phylogenetic analysis of variants resistant to interferon-based protease inhibitor therapy in chronic hepatitis induced by genotype 1b hepatitis C virus.Dengue Virus Evolution under a Host-Targeted Antiviral.Use of illumina deep sequencing technology to differentiate hepatitis C virus variants.Analysis of hepatitis C virus intrahost diversity across the coding region by ultradeep pyrosequencingSpouse-to-Spouse Transmission and Evolution of Hypervariable Region 1 and 5' Untranslated Region of Hepatitis C Virus Analyzed by Next-Generation SequencingResistance analysis of the hepatitis C virus NS3 protease inhibitor asunaprevirNaturally occurring mutations to HCV protease inhibitors in treatment-naïve patients.Rapid hepatitis C virus divergence among chronically infected individuals.Deep-sequencing analysis of the association between the quasispecies nature of the hepatitis C virus core region and disease progression.Quantitative characterization of defective virus emergence by deep sequencingResistance-associated variants in chronic hepatitis C patients treated with protease inhibitors.Application of next-generation sequencing technologies in virology.Increased replicative fitness can lead to decreased drug sensitivity of hepatitis C virus.Response of hepatitis C virus to long-term passage in the presence of alpha interferon: multiple mutations and a common phenotype.Hepatitis C variability, patterns of resistance, and impact on therapyEfficacy and safety of telaprevir in patients with genotype 1 hepatitis C infection.Targeting a host-cell entry factor barricades antiviral-resistant HCV variants from on-therapy breakthrough in human-liver mice.Rapid emergence of telaprevir resistant hepatitis C virus strain from wildtype clone in vivo.Resistance Analysis of a 3-Day Monotherapy Study with Glecaprevir or Pibrentasvir in Patients with Chronic Hepatitis C Virus Genotype 1 InfectionDetection by Direct Next Generation Sequencing Analysis of Emerging Enterovirus D68 and C109 Strains in an Environmental Sample From Scotland
P2860
Q26740219-F55B2813-559C-4E7F-A0A2-0C38D7480412Q26774374-3A1D8B4A-8B1A-4D02-A5CB-CBC92FFB9B65Q27013917-2CEFBA4B-48B0-467A-BAD7-157494C6C298Q27468888-F4785A63-FDC1-4F2E-9584-85BCE3EA0D89Q28481038-55BDC4E1-5139-4693-B124-6E98B3C1094AQ28541048-A79518D5-FF76-4249-B43E-1ADC19F018E1Q34083431-79CDE829-C62A-41BD-B6E9-DD3F64C59BC9Q34430652-9BF1E245-47C2-4A88-8DB0-FD91A6873F39Q35064369-60B113DF-4A1F-4001-AB7D-8FABDC922DEAQ35600172-D9AB6E79-0946-4767-88D2-38EE4359FEDEQ35641185-63A7AA74-D825-4172-8A62-3D1FF707C891Q35641391-3DE9549E-996F-4E85-8D5F-9D8A9A3B085EQ35806939-E83931AD-8E4B-4AA8-AF96-DBE7ABDA31C6Q35826862-2AB79AD9-EA04-45BB-84F2-FCD73A2350EFQ35936933-7C1554A5-CE1C-4573-9680-FA401A2C002CQ36086454-C0CCE818-2FBF-4C62-B73C-AB9473F2600BQ36384127-8F3C8117-499E-440D-AF57-AA5E3DA4FE6FQ36558964-3E023085-0642-4398-AB11-1580002D003BQ37336542-CA757E3D-D418-4271-A10A-AABB32CB8AF9Q37643964-B2E72ABA-48B6-454F-9A8A-A0D2D65F186FQ37967467-5FD3878A-3C88-460C-8EF0-BE90E98AA140Q38014611-541B00B0-1361-4EF1-A530-94553F8E81F5Q38966123-4B0A0B93-014F-4B2F-94F3-E44A80708637Q39157496-4C4BB124-E683-4056-BD64-0C3F079ECE15Q39576325-9CCB9999-EE70-48D7-BFF3-7BB3B4B3A8DDQ39640069-57565754-99AA-44A6-97B4-9082B578F23FQ41033867-D5CAA3D9-ED96-416B-B028-F477DEF56FF8Q43037298-10952406-C8C4-4DC2-AAFE-7FF0F277F36CQ58697287-63D5B1A0-D065-43EB-B16A-64DADAD913D4Q58729188-A6D91A72-6949-41F9-A5BD-77ECAC65B7DB
P2860
Tracking the evolution of multiple in vitro hepatitis C virus replicon variants under protease inhibitor selection pressure by 454 deep sequencing.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Tracking the evolution of mult ...... essure by 454 deep sequencing.
@en
Tracking the evolution of mult ...... essure by 454 deep sequencing.
@nl
type
label
Tracking the evolution of mult ...... essure by 454 deep sequencing.
@en
Tracking the evolution of mult ...... essure by 454 deep sequencing.
@nl
prefLabel
Tracking the evolution of mult ...... essure by 454 deep sequencing.
@en
Tracking the evolution of mult ...... essure by 454 deep sequencing.
@nl
P2093
P2860
P356
P1433
P1476
Tracking the evolution of mult ...... essure by 454 deep sequencing.
@en
P2093
Gregory Fanning
Herwig Van Marck
Ina Vandenbroucke
Kenneth Simmen
Leen Vijgen
Marijke Claes
Oliver Lenz
Thierry Verbinnen
P2860
P304
11124-11133
P356
10.1128/JVI.01217-10
P407
P50
P577
2010-08-25T00:00:00Z